chr16-67652004-A-G

Variant names:

• chr16-67652004-A-G
• rs769736838
• NM_001013838.3:c.2672A>G

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2 BP4_Strong

The NM_001013838.3(CARMIL2):​c.2672A>G​(p.Gln891Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. Q891P) has been classified as Uncertain significance.

• Frequency: Genomes: not found (cov: 32)
• Consequence: CARMIL2 NM_001013838.3 missense
• Clinical Significance: Not reported in ClinVar
• Conservation: PhyloP100: 0.243
• Publications: 0 publications found

Genes affected

CARMIL2 (HGNC:27089): (capping protein regulator and myosin 1 linker 2) This gene encodes a member of the CARMIL (capping protein, Arp2/3, myosin-I linker) family of proteins. The encoded protein interacts with and negatively regulates the heterodimeric capping protein and promotes cell migration. Reduced expression of this gene has been observed in human psoriasis patients. Mutations in this gene cause a human immunodeficiency syndrome characterized by smooth muscle tumors and impaired T-cell function. [provided by RefSeq, May 2017]

CARMIL2 Gene-Disease associations (from GenCC):

• severe combined immunodeficiency due to CARMIL2 deficiency

  Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P, Orphanet

ACMG classification

Our verdict: Likely_benign. The variant received -2 ACMG points.

• PM2: Very rare variant in population databases, with high coverage
• BP4: Computational evidence support a benign effect (MetaRNN=0.013326347).

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001013838.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected	Gene	Transcript	Tags	HGVSc	HGVSp	Effect	Exon Rank	Protein	UniProt
	CARMIL2	NM_001013838.3	MANE Select	c.2672A>G	p.Gln891Arg	missense	Exon 26 of 38	NP_001013860.1
	CARMIL2	NM_001438835.1		c.2564A>G	p.Gln855Arg	missense	Exon 27 of 39	NP_001425764.1
	CARMIL2	NM_001438244.1		c.2564A>G	p.Gln855Arg	missense	Exon 27 of 39	NP_001425173.1

Ensembl Transcripts

Selected	Gene	Transcript	Tags	HGVSc	HGVSp	Effect	Exon Rank	Protein	UniProt
	CARMIL2	ENST00000334583.11	TSL:1 MANE Select	c.2672A>G	p.Gln891Arg	missense	Exon 26 of 38	ENSP00000334958.5
	CARMIL2	ENST00000545661.5	TSL:1	c.2564A>G	p.Gln855Arg	missense	Exon 27 of 38	ENSP00000441481.1
	CARMIL2	ENST00000696175.1		c.2579A>G	p.Gln860Arg	missense	Exon 27 of 39	ENSP00000512465.1

Frequencies

GnomAD3 genomes Cov.: 32

GnomAD4 exome Cov.: 32

GnomAD4 genome Cov.: 32

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name	Calibrated prediction	Score	Prediction
AlphaMissense	Benign	0.053
BayesDel_addAF	Benign	-0.34	T
BayesDel_noAF	Benign	-0.72
CADD	Benign	8.6
DANN	Benign	0.56
DEOGEN2	Benign	0.012	T
Eigen	Benign	-1.7
Eigen_PC	Benign	-1.5
FATHMM_MKL	Benign	0.0075	N
LIST_S2	Benign	0.27	T
M_CAP	Benign	0.0042	T
MetaRNN	Benign	0.013	T
MetaSVM	Benign	-0.95	T
PhyloP100		0.24
PrimateAI	Benign	0.34	T
PROVEAN	Benign	0.99	N
REVEL	Benign	0.022
Sift	Benign	0.76	T
Sift4G	Benign	1.0	T
Polyphen		0.0	B
Vest4		0.028
MutPred		0.21		Loss of helix (P = 0.0093)
MVP		0.067
MPC		0.19
ClinPred		0.084	T
GERP RS		0.58
Varity_R		0.031
gMVP		0.15

Splicing

Name	Calibrated prediction	Score	Prediction
SpliceAI score (max)		0.060		Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Other links and lift over

dbSNP: rs769736838; hg19: chr16-67685907;